文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肾脏炎症性疾病中的细胞外囊泡:揭示细胞外囊泡介导的巨噬细胞调节机制

Extracellular Vesicles in Renal Inflammatory Diseases: Revealing Mechanisms of Extracellular Vesicle-Mediated Macrophage Regulation.

作者信息

Wei Jiatai, Xie Zijie, Kuang Xiaodong

机构信息

The Second Clinical Medical College, Nanchang University, Nanchang 330031, China.

Pathology Teaching and Research Office, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.

出版信息

Int J Mol Sci. 2025 Apr 12;26(8):3646. doi: 10.3390/ijms26083646.


DOI:10.3390/ijms26083646
PMID:40332144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12027779/
Abstract

Renal inflammatory diseases are a group of severe conditions marked by significant morbidity and mortality. Extracellular vesicles (EVs), as facilitators of intercellular communication, have been recognized as pivotal regulators of renal inflammatory diseases, significantly contributing to these conditions by modulating immune responses among other mechanisms. This review highlights the intricate mechanisms through which EVs modulate macrophage-kidney cell interactions by regulating macrophages, the principal immune cells within the renal milieu. This regulation subsequently influences the pathophysiology of renal inflammatory diseases such as acute kidney injury and chronic kidney disease. Furthermore, understanding these mechanisms offers novel opportunities to alleviate the severe consequences associated with renal inflammatory diseases. In addition, we summarize the therapeutic landscape based on EV-mediated macrophage regulatory mechanisms, highlighting the potential of EVs as biomarkers and therapeutic targets as well as the challenges and limitations of translating therapies into clinical practice.

摘要

肾脏炎性疾病是一组具有显著发病率和死亡率的严重病症。细胞外囊泡(EVs)作为细胞间通讯的促进者,已被公认为肾脏炎性疾病的关键调节因子,通过调节免疫反应等机制对这些病症产生重大影响。本综述重点介绍了细胞外囊泡通过调节巨噬细胞(肾脏微环境中的主要免疫细胞)来调节巨噬细胞与肾脏细胞相互作用的复杂机制。这种调节随后会影响诸如急性肾损伤和慢性肾病等肾脏炎性疾病的病理生理学。此外,了解这些机制为减轻与肾脏炎性疾病相关的严重后果提供了新的机会。此外,我们基于细胞外囊泡介导的巨噬细胞调节机制总结了治疗前景,强调了细胞外囊泡作为生物标志物和治疗靶点的潜力,以及将治疗方法转化为临床实践所面临的挑战和局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/1b4a988182e9/ijms-26-03646-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/2a26d9293a11/ijms-26-03646-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/f54bcbbdc0c5/ijms-26-03646-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/ea60c90554e0/ijms-26-03646-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/1b4a988182e9/ijms-26-03646-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/2a26d9293a11/ijms-26-03646-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/f54bcbbdc0c5/ijms-26-03646-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/ea60c90554e0/ijms-26-03646-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2c/12027779/1b4a988182e9/ijms-26-03646-g004.jpg

相似文献

[1]
Extracellular Vesicles in Renal Inflammatory Diseases: Revealing Mechanisms of Extracellular Vesicle-Mediated Macrophage Regulation.

Int J Mol Sci. 2025-4-12

[2]
Macrophage-driven inflammation in acute kidney injury: Therapeutic opportunities and challenges.

Transl Res. 2025-4

[3]
Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury.

Int J Mol Sci. 2021-6-20

[4]
Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.

Stem Cell Res Ther. 2017-12-4

[5]
Extracellular vesicles in diagnosis and therapy of kidney diseases.

Am J Physiol Renal Physiol. 2016-11-1

[6]
Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases.

Int J Mol Sci. 2016-6-30

[7]
Crosstalk between macrophages and adjacent cells in AKI to CKD transition.

Ren Fail. 2025-12

[8]
Extracellular vesicles: Illuminating renal pathophysiology and therapeutic frontiers.

Eur J Pharmacol. 2024-9-5

[9]
IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.

Int Immunopharmacol. 2021-11

[10]
Regulation of regulated cell death by extracellular vesicles in acute kidney injury and chronic kidney disease.

Cytokine Growth Factor Rev. 2024-4

本文引用的文献

[1]
Neutrophils and NETs in kidney disease.

Nat Rev Nephrol. 2025-3-18

[2]
Therapeutic role of hucMSC-sEV-enriched miR-13896 in cisplatin-induced acute kidney injury through M2 macrophage polarization.

Cell Biol Toxicol. 2025-2-24

[3]
Senescent renal tubular cells derived extracellular vesicles transported miR-20a and miR-21 induced macrophage-to-myofibroblast transition in renal fibrosis after ischemia reperfusion injury.

Int J Biol Sci. 2025-1-6

[4]
Exosomes derived from TREM-2 knocked-out macrophages alleviated renal fibrosis via HSPa1b/AKT pathway.

Am J Physiol Renal Physiol. 2025-1-1

[5]
Advances in macrophage-myofibroblast transformation in fibrotic diseases.

Front Immunol. 2024

[6]
Mesoporous Microneedles Enabled Localized Controllable Delivery of Stimulator of Interferon Gene Agonist Nanoexosomes for FLASH Radioimmunotherapy against Breast Cancer.

ACS Appl Mater Interfaces. 2024-10-30

[7]
Exosomal let-7b-5p deriving from parietal epithelial cells attenuate renal fibrosis through suppression of TGFβR1 and ARID3a in obstructive kidney disease.

FASEB J. 2024-10-15

[8]
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease.

Nat Rev Nephrol. 2025-1

[9]
Engineering therapeutical extracellular vesicles for clinical translation.

Trends Biotechnol. 2025-1

[10]
Macrophage autophagy protects against acute kidney injury by inhibiting renal inflammation through the degradation of TARM1.

Autophagy. 2025-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索